Legacy Capital Group California, Inc.

Position in JNJ — Johnson & Johnson

CIK 1977092 LOS GATOS, CA

Position in JNJ

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,525,343

+$68,481 QoQ

Shares Held

6,006

+0.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

#2,593

of 4,676 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

Legacy Capital Group California, Inc. holds $8,650,056 across 9 Drug Manufacturers - General names. JNJ ranks #2 (17.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	19,689	$2,530,036
2	JNJ	Johnson & Johnson This page	6,006	$1,525,343
3	PFE	Pfizer Inc	37,682	$907,382
4	BMY	Bristol Myers Squibb Co	15,052	$867,296
5	AMGN	Amgen Inc	2,351	$851,344
6	BIIB	Biogen Inc.	2,844	$614,474
7	GILD	Gilead Sciences, Inc.	4,088	$516,477
8	NVO	Novo Nordisk A S	10,299	$493,734

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,525,343	6,006	+0.8%	Shares	Sole	2026-07-29
2026-03-31	$1,456,862	5,960	-39.5%	Shares	Sole	2026-05-04
2025-12-31	$2,039,078	9,853	+17.1%	Shares	Sole	2026-01-28
2025-09-30	$1,560,494	8,416	-38.3%	Shares	Sole	2025-11-12
2025-06-30	$2,084,273	13,645	-1.2%	Shares	Sole	2025-07-14
2025-03-31	$2,289,421	13,805	+1.8%	Shares	Sole	2025-05-09
2024-12-31	$1,961,914	13,566	+1.1%	Shares	Sole	2025-02-03
2024-09-30	$2,173,548	13,412	+1.1%	Shares	Sole	2024-10-23
2024-06-30	$1,939,543	13,270	+100.7%	Shares	Sole	2024-07-22
2024-03-31	$1,045,794	6,611	+0.1%	Shares	Sole	2024-05-07
2023-12-31	$1,035,581	6,607	+3.1%	Shares	Sole	2024-02-13
2023-09-30	$997,890	6,407	+2.4%	Shares	Sole	2023-11-06
2023-06-30	$1,035,327	6,255	+18.4%	Shares	Sole	2023-08-10
2023-03-31	$819,020	5,284	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.